670 related articles for article (PubMed ID: 33071558)
1. Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.
Gambino CM; Lo Sasso B; Colomba C; Giglio RV; Agnello L; Bivona G; Ciaccio M
Biochem Med (Zagreb); 2020 Oct; 30(3):030901. PubMed ID: 33071558
[TBL] [Abstract][Full Text] [Related]
2. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
[TBL] [Abstract][Full Text] [Related]
3. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
4. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M
J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180
[TBL] [Abstract][Full Text] [Related]
5. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics.
Padoan A; Cosma C; Sciacovelli L; Faggian D; Plebani M
Clin Chem Lab Med; 2020 Jun; 58(7):1081-1088. PubMed ID: 32301749
[TBL] [Abstract][Full Text] [Related]
6. Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection.
Lijia S; Lihong S; Huabin W; Xiaoping X; Xiaodong L; Yixuan Z; Pin H; Yina X; Xiaoyun S; Junqi W
J Clin Lab Anal; 2020 Oct; 34(10):e23466. PubMed ID: 32671890
[TBL] [Abstract][Full Text] [Related]
7. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
[TBL] [Abstract][Full Text] [Related]
8. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays.
Qian C; Zhou M; Cheng F; Lin X; Gong Y; Xie X; Li P; Li Z; Zhang P; Liu Z; Hu F; Wang Y; Li Q; Zhu Y; Duan G; Xing Y; Song H; Xu W; Liu BF; Xia F
Clin Chem Lab Med; 2020 Aug; 58(9):1601-1607. PubMed ID: 32609640
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
Velay A; Gallais F; Benotmane I; Wendling MJ; Danion F; Collange O; De Sèze J; Schmidt-Mutter C; Schneider F; Bilbault P; Meziani F; Fafi-Kremer S
Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115181. PubMed ID: 32957073
[TBL] [Abstract][Full Text] [Related]
10. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
Cai XF; Chen J; Li Hu J; Long QX; Deng HJ; Liu P; Fan K; Liao P; Liu BZ; Wu GC; Chen YK; Li ZJ; Wang K; Zhang XL; Tian WG; Xiang JL; Du HX; Wang J; Hu Y; Tang N; Lin Y; Ren JH; Huang LY; Wei J; Gan CY; Chen YM; Gao QZ; Chen AM; He CL; Wang DX; Hu P; Zhou FC; Huang AL; Wang DQ
J Infect Dis; 2020 Jun; 222(2):189-193. PubMed ID: 32382737
[TBL] [Abstract][Full Text] [Related]
11. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.
Pérez-García F; Pérez-Tanoira R; Romanyk J; Arroyo T; Gómez-Herruz P; Cuadros-González J
J Clin Virol; 2020 Aug; 129():104473. PubMed ID: 32504945
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19.
Imai K; Tabata S; Ikeda M; Noguchi S; Kitagawa Y; Matuoka M; Miyoshi K; Tarumoto N; Sakai J; Ito T; Maesaki S; Tamura K; Maeda T
J Clin Virol; 2020 Jul; 128():104393. PubMed ID: 32387968
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
[TBL] [Abstract][Full Text] [Related]
15. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies.
Montesinos I; Gruson D; Kabamba B; Dahma H; Van den Wijngaert S; Reza S; Carbone V; Vandenberg O; Gulbis B; Wolff F; Rodriguez-Villalobos H
J Clin Virol; 2020 Jul; 128():104413. PubMed ID: 32403010
[TBL] [Abstract][Full Text] [Related]
17. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
[TBL] [Abstract][Full Text] [Related]
18. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis.
Liu W; Kou G; Dong Y; Zheng Y; Ding Y; Ni W; Wu W; Tang S; Xiong Z; Zhang Y; Liu L; Zheng S
J Clin Virol; 2020 Sep; 130():104576. PubMed ID: 32763810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]